Skip to main content
COVID-19

Medical Policy Implementation: Assay for Chronic Heart Failure

Effective June 22, 2015, Horizon Blue Cross Blue Shield of New Jersey will change the way we consider certain claims for clinical laboratory tests to determine the progression of cardiac disease.

Based on the guidelines of our medical policy, Assay for Chronic Heart Failure, CPT® code 83006 submitted on claims for services provided on June 22, 2015 and after will be denied as an investigational/experimental service.

Review this revised policy in our online Medical Policy Manual.

Unless Horizon BCBSNJ gives written notice that all or part of the above changes have been cancelled or postponed, the changes will be applied to claims for dates of service on and after June 22, 2015.

CPT® is a registered mark of the American Medical Association.

Published on: March 23, 2015, 08:00 a.m. ET
Last updated on: November 24, 2020, 23:33 p.m. ET